Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring

Hypertension

Volumn 27, Issue 6, 1996, Pages 1200-1204

  Lindsay, Robert S ^a   Lindsay, R Mark ^a   Edwards, Christopher R W ^a   Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

birth weight; blood pressure; carbenoxolone; corticosterone; glucocorticoid

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTEROID METABOLISM; FETOPLACENTAL UNIT; HYPERTENSION; LOW BIRTH WEIGHT; NONHUMAN; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0029948716     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.6.1200     Document Type: Article

References (67)

1. Barker DJP, Osmond C, Goldings J, Kuh D, Wadsworth MEJ. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J. 1989;298:564-567.
2. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. Br Med J. 1990;301:259-263.
3. Law CM, Barker DJP, Bull AR, Osmond C. Maternal and fetal influences on blood pressure. Arch Dis Child. 1991;66:1291-1295.
4. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J. 1991;303:1019-1022.
5. Gennser G, Rymark P, Isberg P. Low birthweight and the risk of high blood pressure in adulthood. Br Med J. 1988;296:1498-1500.
6. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clarke PMS. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36:62-67.
7. McCance D, Pettitt D, Hanson R, Jacobsson L, Knowler W, Bennett P. Birthweight and non-insulin-dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? Br Med J. 1994;308:942-945.
8. Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2:577-580.
9. Osmond C, Barker D, Winter P, Fall C, Simmonds S. Early growth and death from cardiovascular disease in women. Br Med J. 1993; 307:1524-1527.
10. Barker D, Osmond C, Simmonds S, Wield G. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. Br Med J. 1993;306:422-426.
11. Barker DJP. Fetal and Infant Origins of Adult Disease. London, UK: British Medical Journal; 1991.
12. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341:938-941.
13. Lever AF, Harrap SB. Essential hypertension: a disorder of growth with origins in childhood? J Hypertens. 1992;10:101-120.
14. Williams S, St George IM, Silva PA. Intrauterine growth retardation and blood pressure at age seven and eighteen. J Clin Epidemiol. 1992;42:1257-1273.
15. Whincup P, Cook D, Papacosta O. Do maternal and intrauterine factors influence blood pressure in childhood? Arch Dis Child. 1992; 67:1423-1429.
16. Launer L, Hofman A. Grobbee D. Relation between birthweight and blood pressure: longitudinal study of infants and children. Br Med J. 1993;307:1451-1454.
17. Kolacek S, Kapetenovic T, Luzar V. Early determinants of cardiovascular risk factors in adults. Acta Paediatr. 1993;82:377-382.
18. Law CM, de Swiet M, Osmond C, Fayers PM, Barker DJP, Crudas AM, Fall CHD. Initiation of hypertension in utero and its amplification throughout life. Br Med J. 1993;306:24-27.
19. Matthes J, Lewis P, Davies D, Bethel J. Relation between birth weight at term and systolic blood pressure in adolescence. Br Med J. 1994;308:1074-1077.
20. Gillman M, Ellison R. Childhood prevention of essential hypertension. Pediatr Clin North Am. 1993;40:179-194.
21. Godfrey KM, Redman CWG, Barker DJP, Osmond C. The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol. 1991;98:886-891.
22. Langley SC, Jackson AA. Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci. 1994;86:217-222.
23. Lucas A, Morley R. Does early nutrition in infants born before term programme later blood pressure? Br Med J. 1994;309:304-308.
24. Edwards CRW, Benediktsson R, Lindsay R, Seckl JR. Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension? Lancet. 1993;341:355-357.
25. Seckl JR. Glucocorticoids and small babies. Q J Med. 1994;87: 259-262.
26. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab. 1993; 77:1174-1179.
27. Reinisch JM, Simon NG, Karwo WG, Gandleman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science. 1978;202:436-438.
28. Novy MJ, Walsh SW. Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestation length, maternal plasma hormones and fetal growth. Am J Obstet Gynecol. 1983;145: 920-930.
29. Mosier HD Jr. Dearden LC, Jansons RA, Roberts RC, Biggs CS. Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther. 1982;4: 89-105.
30. Bian XP, Seidler FJ, Slotkin TA. Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology. 1993:47:109-117.
31. Ross EJ, Marshall-Jones P, Friedman M. Cushing's syndrome: diagnostic criteria. Q J Med. 1966;35:149-192.
32. Tonolo G, Fraser R, Connell JMC, Kenyon CJ. Chronic low-dose infusions of dexamethasone in rats: effect on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens. 1988;6:25-31.
33. Tangalakis K, Lumbers ER, Moritz KM, Towstoless MK, Wintour EM. Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol. 1992;77:709-717.
34. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards C. Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet. 1993;341:339-341.
35. Brown R, Chapman K, Kotoletsev Y, Yau J, Lindsay R, Brett L, Leckie C, Murad P, Lyons V, Mullins J, Edwards C, Seckl J. Cloning and production of antisera to human placental 11β-hydroxy-steroid dehydrogenase type 2. Biochem J. 1996;313:1007-1017.
36. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Human placental 11β-hydroxysteroid dehydrogenase: partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinology. 1993;132:2614-2621.
37. Murphy BEP, Clark SJ, Donald IR, Pinsky M, Vedady DL. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol. 1974;118:538-541.
38. Stewart P, Rogerson F, Mason J. Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birthweight and putative role in fetal steroidogenesis. J clin Endocrinol Metab. 1995;80:885-890.
39. Benediktsson R, Noble J, Calder A, Edwards C, Seckl J. 11β-hydroxysteroid dehydrogenase efficiency in the intact placenta and birthweight in humans. American Endocrine Society Abstracts. 1995; P3:641. Abstract.
40. Mune T, Rogerson F, Nikkila H, Agarwal A, White P. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet. 1995;10:394-399.
41. Seckl JR. 11β-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest. 1993; 23:589-601.
42. Monder C, White PC. 11β-hydroxysteroid dehydrogenase. Vitam Horm. 1993;47:187-271.
43. Armanini D, Karbowiak I, Funder JW. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf). 1983;19:609-612.
44. Monder C, Stewart PM, Lakshmi V, Valentino R, Burl D, Edwards CRW. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 1989; 125:1046-1053.
45. Monder C. Corticosteroids, kidneys, sweet roots and dirty drugs. Mol Cell Endocrinol. 1991;78:C95-C98.
46. Baker ME, Fanestil DD, Liquorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action. Mol Cell Endocrinol. 1991;78:C99-C102.
47. Latif S, Conca T, Morris D. The effects of the liquorice derivative, glycyrrhetinic acid on hepatic 3α- and 3β-hydroxysteroid dehydrogenases and 5α- and 5β-reductase pathways of metabolism of al-dosterone in male rats. Steroids. 1990;55:52-58.
48. Teelucksingh S, Benediktsson R, Lindsay RS, Burt D, Seckl JR, Edwards CRW, Nan C-L, Kelly R. Liquorice. Lancet. 1991;337:1549. Letter.
49. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
50. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242:583-585.
51. Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2: 821-824.
52. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci. 1990;78:49-54.
53. Breschi MC, Seghieri G, Bartolemei G, Gironi A, Baldi S, Ferrannini E. Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia. 1993;36:1315-1321.
54. Beitens IZ, Bayard F, Ances IG. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res. 1973;7:509-519.
55. Bihoreau MT, Ktorza A, Kinebanyan MF, Picon L. Impaired glucose homeostasis in adult rats from hyperglycemic mothers. Diabetes. 1986;35:979-984.
56. Linn T, Leowk E, Schneider K, Federlin K. Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice. Diabetologia. 1993;36:1245-1251.
57. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes. 1987;37:622-628.
58. Moisan M-P, Edwards CRW, Seckl JR. Ontogeny of 11β-hydroxysteroid dehydrogenase in rat brain and kidney. Endocrinology. 1992; 130:400-404.
59. Yang K, Smith CL, Dales D, Hammond GL, Challis JR. Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology. 1992;131:2120-2126.
60. Stewart P, Murry B, Mason J. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab. 1994;78: 1529-1532.
61. Navarro HA, Kudlacz EM, Eylers JP, Slotkin TA. Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. Teratology. 1989;40:433-438.
62. Huff RA, Seidler FJ, Slotkin TA. Glucocorticoids regulate the ontogenic transition of adrenergic receptor subtypes in rat liver. Life Sci. 1991;48:1059-1065.
63. Bian XP, Seidler FJ, Slotkin TA. Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol. 1992;17:289-297.
64. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science. 1988;239:766-768.
65. O'Donnell D, La Roque S, Seckl JR, Meaney M. Postnatal handling alters glucocorticoid but not mineralocorticoid receptor mRNA expression in the hippocampus of adult rats. Mol Brain Res. 1994;26:242-248.
66. Price WA, Stiles AD, Moats-Staats BM, D'Ercole AJ. Gene-expression of the insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology. 1992;130:1424-1432.
67. Li J, Saunders JC, Gilmour RS, Silver M, Fowden AL. Insulin-like growth factor-II messenger RNA expression in fetal tissues of the sheep during late gestation: effects of cortisol. Endocrinology. 1993; 132:2083-2089.